FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285286031> ?p ?o ?g. }

• W4285286031 endingPage "283" @default.
• W4285286031 startingPage "269" @default.
• W4285286031 abstract "According to a recent analysis, nearly 450 million people get affected by type 2 diabetes, which corresponds to 6.28% of our population. Type 2 diabetes has become one of the ten leading causes of death worldwide. This disease reports over 10 lakh deaths per year, with a current widespread reporting rate of 6000 cases per 100,000; the rate is reckoned to increase to 7100 patients per 100,000 by the end of 2030 (Yang et al. 2018). Diabetes mellitus requires immediate attention because of its increasing burden globally, especially in developed nations, such as America and Europe. Alpha-glucosidase inhibitors are a class of oral medication used in treating type 2 diabetes mellitus. They can be administered alone or in combination therapy with other antidiabetic medications. They are used for patients with low blood sugar tolerance and delayed type 2 diabetes. They are convenient for patients at risk of hypoglycemia or lactic acidosis. Thus, they are not suitable candidates which are on other antidiabetic drugs such as sulfonylureas and biguanides. Alpha-glucosidase inhibitors can also be referred to as starch blockers that help to reduce postprandial blood sugar levels . These enzyme inhibitors do not directly affect insulin secretion or sensitivity, unlike other antidiabetic drugs. Instead, they work by delaying the digestion of sugars found in starchy foods by raising post-meal levels of GLP-1 and lowering HbA1c levels. Alpha-glucosidase inhibitors like acarbose and migitol have shown an increase in expectancy of life in patients with type 2 diabetes mellitus and have proven reduced risk of cardiovascular incidents in patients with reduced glucose tolerance. It has also proven to be effective in stabilizing carotid plaques, lowering hyperglycemia, and can very well counter oxidative stress and endothelial dysfunction." @default.
• W4285286031 created "2022-07-14" @default.
• W4285286031 creator A5001020526 @default.
• W4285286031 creator A5022487296 @default.
• W4285286031 date "2022-01-01" @default.
• W4285286031 modified "2023-10-03" @default.
• W4285286031 title "α-Glucosidase Inhibitors for Diabetes/Blood Sugar Regulation" @default.
• W4285286031 cites W1479698458 @default.
• W4285286031 cites W1636104439 @default.
• W4285286031 cites W1946502985 @default.
• W4285286031 cites W1968892236 @default.
• W4285286031 cites W1970437660 @default.
• W4285286031 cites W1985108159 @default.
• W4285286031 cites W1990657948 @default.
• W4285286031 cites W2003947308 @default.
• W4285286031 cites W2018395518 @default.
• W4285286031 cites W2022778645 @default.
• W4285286031 cites W2025419894 @default.
• W4285286031 cites W2025742657 @default.
• W4285286031 cites W2047531818 @default.
• W4285286031 cites W2047994751 @default.
• W4285286031 cites W2069377001 @default.
• W4285286031 cites W2069986475 @default.
• W4285286031 cites W2074083072 @default.
• W4285286031 cites W2082153808 @default.
• W4285286031 cites W2120399697 @default.
• W4285286031 cites W2148509363 @default.
• W4285286031 cites W2150471827 @default.
• W4285286031 cites W2162590815 @default.
• W4285286031 cites W2340770434 @default.
• W4285286031 cites W2345060061 @default.
• W4285286031 cites W2514767773 @default.
• W4285286031 cites W2603591350 @default.
• W4285286031 cites W2731639437 @default.
• W4285286031 cites W2736029153 @default.
• W4285286031 cites W2891221355 @default.
• W4285286031 cites W2898266729 @default.
• W4285286031 cites W2901042565 @default.
• W4285286031 cites W2907782951 @default.
• W4285286031 cites W2913054963 @default.
• W4285286031 cites W2926426577 @default.
• W4285286031 cites W2939249836 @default.
• W4285286031 cites W2968581435 @default.
• W4285286031 cites W2969629179 @default.
• W4285286031 cites W2972869264 @default.
• W4285286031 cites W2979880398 @default.
• W4285286031 cites W2981518433 @default.
• W4285286031 cites W3004806199 @default.
• W4285286031 cites W3005370270 @default.
• W4285286031 cites W3011967545 @default.
• W4285286031 cites W3012997578 @default.
• W4285286031 cites W3038371998 @default.
• W4285286031 cites W3083494942 @default.
• W4285286031 cites W3092065440 @default.
• W4285286031 cites W3093084526 @default.
• W4285286031 cites W3165268108 @default.
• W4285286031 cites W3193722096 @default.
• W4285286031 cites W4230517355 @default.
• W4285286031 cites W568495147 @default.
• W4285286031 cites W58694390 @default.
• W4285286031 doi "https://doi.org/10.1007/978-981-19-0932-0_12" @default.
• W4285286031 hasPublicationYear "2022" @default.
• W4285286031 type Work @default.
• W4285286031 citedByCount "2" @default.
• W4285286031 countsByYear W42852860312022 @default.
• W4285286031 countsByYear W42852860312023 @default.
• W4285286031 crossrefType "book-chapter" @default.
• W4285286031 hasAuthorship W4285286031A5001020526 @default.
• W4285286031 hasAuthorship W4285286031A5022487296 @default.
• W4285286031 hasConcept C126322002 @default.
• W4285286031 hasConcept C134018914 @default.
• W4285286031 hasConcept C2776617576 @default.
• W4285286031 hasConcept C2777180221 @default.
• W4285286031 hasConcept C2778199505 @default.
• W4285286031 hasConcept C2779284873 @default.
• W4285286031 hasConcept C2779306644 @default.
• W4285286031 hasConcept C2780485761 @default.
• W4285286031 hasConcept C2780668416 @default.
• W4285286031 hasConcept C2908647359 @default.
• W4285286031 hasConcept C2910068830 @default.
• W4285286031 hasConcept C555293320 @default.
• W4285286031 hasConcept C71924100 @default.
• W4285286031 hasConcept C98274493 @default.
• W4285286031 hasConcept C99454951 @default.
• W4285286031 hasConceptScore W4285286031C126322002 @default.
• W4285286031 hasConceptScore W4285286031C134018914 @default.
• W4285286031 hasConceptScore W4285286031C2776617576 @default.
• W4285286031 hasConceptScore W4285286031C2777180221 @default.
• W4285286031 hasConceptScore W4285286031C2778199505 @default.
• W4285286031 hasConceptScore W4285286031C2779284873 @default.
• W4285286031 hasConceptScore W4285286031C2779306644 @default.
• W4285286031 hasConceptScore W4285286031C2780485761 @default.
• W4285286031 hasConceptScore W4285286031C2780668416 @default.
• W4285286031 hasConceptScore W4285286031C2908647359 @default.
• W4285286031 hasConceptScore W4285286031C2910068830 @default.
• W4285286031 hasConceptScore W4285286031C555293320 @default.
• W4285286031 hasConceptScore W4285286031C71924100 @default.
• W4285286031 hasConceptScore W4285286031C98274493 @default.

• next